Analysis | High drug prices are not justified by industry’s spending on research and development

High drug prices are not justified by industry’s spending on research and development – The BMJ

News Release: Drug prices not justified by industry’s research and development spending – BMJ Newsroom

Commentary: Pharmaceutical companies can develop more innovative and affordable medicines by refocusing their spending but government intervention is needed – London School of Hygiene & Tropical Medicine

Commentary from the author on Twitter (thread – click for more)

New @bmj_latest paper📭

High drug prices do not seem justified by pharma industry’s R&D spending & new drugs' added benefits 💊💰
How can companies develop more innovative & affordable medicines?

Read the thread 🧵https://t.co/YYznD4Tvwq@ojwouters @ElsTorreele @martinmckee

— Aris Angelis – Άρης Αγγελής (@aris_angelis) February 16, 2023